Striking homology between signaling molecules in zebrafish and humans suggests that compounds known to inhibit human kinases may enable a chemical genetic approach to dissect signaling pathways in the zebrafish embryo. We tested this hypothesis using a vascular endothelial growth factor receptor inhibitor, PTK787/ZK222584. Zebrafish embryos treated with this compound lacked all major blood vessels. Overexpression of AKT/PKB, a putative effector of vascular endothelial growth factor signaling, allowed blood vessels to form in the presence of drug. Endothelial cell apoptosis induced by the drug is prevented by increasing AKT/PKB activity, thus establishing the physiological relevance of AKT/PKB in the angiogenic process. This approach allowed us to examine the effects of blood flow and the role of endothelial signals in organogenesis.
Introduction
ent zebrafish embryo permits easy visual analysis of phenotypic defects. Currently, the simplest method for generating a lossof-function in a particular gene in the zebrafish is the use of Our current knowledge on the physiological function of various genes has benefited from studies using model organisms. Alantisense technology using morpholino oligonucleotides to induce a translational block in gene function (Nasevicius and though informative, targeted gene disruption in mice blocks function at such an early stage that it sometimes hinders the . Although important information can be obtained by morpholino injections, this method, similar to ability to learn about gene function at later stages of development. While conditional loss-of-function experiments are possithe use of null mutations, blocks gene function at the earliest stage. We set out to use a novel strategy to study signal transble in the mouse (reviewed in Lewandoski, 2001; Mills, 2001 ), these technologies do not allow much flexibility in and control duction in the zebrafish embryo using a chemical genetic approach to achieve a rheostatic control of signal strength. We over residual gene function. In other model organisms, such as Drosophila and C. elegans, the use of a controlled modulation used this strategy to study angiogenic signaling in the transparent zebrafish embryo. of gene dosage by temperature-sensitive and partial loss-offunction alleles has generated valuable information on signaling
The need for new blood vessels is important during embryogenesis, as well as in pathological situations such as tumor pathways (reviewed in Rubin, 1991; Simon et al., 1991; Sternberg, 1993; Sternberg and Horvitz, 1991) . However, invertegrowth (reviewed in Carmeliet and Jain, 2000) . Thus, the molecular dissection of angiogenic signaling is clinically relevant. The brates do not possess the extensive circulatory and other organ systems of vertebrates, making them less than ideal for the formation of blood vessels and evaluation of blood flow is extremely easy to score in the zebrafish embryo, making it an study of more complex processes such as angiogenesis and organ development.
ideal model for the study of angiogenesis. The major regulators of angiogenic signaling, the vascular endothelial growth factors The zebrafish provides an alternative vertebrate model system. The fish possesses a complex circulatory system similar (VEGFs) and their receptors (VEGFRs), promote endothelial cell differentiation, survival, and migration (reviewed in Carmeliet, to that of mammals, as well as reasonable counterparts for many, although not all, of the other mammalian organ systems 2000; Ferrara and Alitalo, 1999) . By addition of a kinase inhibitor targeted against the VEGF receptors to the media bathing the (Kimmel et al., 1995; Isogai et al., 2001; Fishman, 2001; Thisse and Zon, 2002) . The rapid external development of the transparfish embryo, we phenocopied the loss of VEGF ligand function
S I G N I F I C A N C E
Our work represents a novel strategy to study signal transduction using a chemical genetic approach in an intact vertebrate organism. The use of a chemical compound to dissect angiogenic signaling has allowed fine tuning of effective gene dosage. As in other genetic models, such as Drosophila, we were able to bypass the receptor blockade by upregulating the activity of a putative downstream effector, AKT/PKB. The combination of chemical genetics and the transparent zebrafish embryo can be used to study other signal transduction pathways as well as for drug evaluation. The assays we have employed here are both inexpensive and facile relative to mouse studies, suggesting that the zebrafish may be used as a preclinical model for drug testing. brought about by morpholino injections, where blood vessel formation was prevented . The chemically induced VEGF receptor defect can be ameliorated by upregulating the activity of a putative downstream effector, AKT/ PKB, allowing for normal endothelial cell functions in migration and survival.
Results
Molecular rationale for using a VEGF receptor inhibitor in zebrafish Preliminary to drug testing, we cloned and sequenced the fulllength zebrafish cDNAs for VEGFR-2/flk-1/KDR as well as for several key members of its downstream signaling apparatus, including PI3-kinase (p110␣ and p85␣), PTEN, and AKT-2/ PKB␤, and found high overall homology to their human counterparts (Figure 1 and J.C. and T.M.R., unpublished data). The zebrafish VEGFR-2/flk-1/KDR cDNA is the full-length version of the partial cDNAs previously reported by several other groups (Fouquet et al., 1997; Liao et al., 1997; Sumoy et al., 1997; Thompson et al., 1998) . The high level of conservation in the tyrosine kinase domain between human and zebrafish VEGFR-2 (78% identity, Figure 1A ) provided a structural basis for use of the antiangiogenic compound PTK787/ZK222584 on zebrafish embryos.
Specific angiogenic inhibition by PTK787/ZK222584 phenocopies functional loss of VEGF-A ligand
PTK787/ZK222584 is a novel anilinophthalazine compound and a high affinity inhibitor of the VEGF receptors, with a higher potency toward VEGFR-2/KDR than VEGFR-1/Flt-1 (IC 50 ϭ 37 nM and 77 nM, respectively; . Although it also exhibits inhibitory activity toward the PDGF, Flt-4, and c-Kit receptors, this occurs at higher concentrations Bold et al., 2000) . Previous studies have shown the effec- Figures 2G-2J ). This results in severe pericardial edema (Figure (Figures 2A and 2B) argues strongly for the selectivity of 2D), with further complications of heart failure and embryonic PTK787/ZK222584 for VEGF receptors. The potent antiangiodeath by 3 days of development. The lack of deleterious effects genic effect of PTK787/ZK222584 is further confirmed by a significant reduction of endothelial cells in the region of the on the general morphology of embryonic structures by 24 hpf dorsal artery and posterior cardinal vein at 24 hpf, and by their fish, a strict requirement for blood flow determines proper glomerular assembly (Serluca et al., 2002) . The lack of aortic blood absence at 48 hpf as indicated by flk-1/VEGFR-2 in situ RNA staining (Figures 2E, 2F, 2I, and 2J) . This is confirmed by the flow in embryos treated at early stages with PTK787/ZK222584 generated defects in glomerulogenesis, as wt1-positive cells distinctive absence of these major blood vessels by 48 hpf when viewed in transverse section (Figures 2G and 2H) . We analyzed remain unmerged at 48 hpf and beyond ( Figures 3D-3F ). However, later administration of drug, after the onset of aortic flow this defect further using established endothelial markers: fli1 for endothelial precursors (Figures 2K and 2L; Thompson et al.,  by 26 hpf, allowed for glomerular assembly, demonstrating that PTK787/ZK222584 does not illicit a deleterious effect on kidney 1998) and ephrin B2a for arterial endothelial cells (Figures 2M and 2N; Chan et al., 2001) , as well as flt4 for venous endothelial development on its own ( Figure 3C ). We also examined the development of the endocrine pancreas (insulin; Figures 3G and cells (Figures 2O and 2P; Thompson et al., 1998) . In all cases, endothelial cell staining was either abolished or significantly 3H; Milewski et al., 1998; Argenton et al., 1999) , the exocrine pancreas (trypsin, Figures 3I and 3J; Biemar et al., 2001) as well reduced in the region of the major dorsal vessels in the PTK787/ ZK222584-treated animal, as compared with same stage conas the liver (fkd2; Figures 3K and 3L; Chen et al., 2001 ) using established in situ markers. In spite of the dramatic reduction trols ( Figures 2I-2P ).
Since early administration of PTK787/ZK222584 resulted in of endothelial cells ( Figures 2E-2P ), all markers are expressed ( Figures 3G-3L ). However, the expression domains for trypsin zebrafish embryos that do not possess an intact dorsal artery or vein and have no aortic blood flow, it prompted us to examine and fkd2 appear shortened along the anterior-posterior axis ( Figures 3I-3L ). organogenesis in treated animals (Serluca et al., 2002; Lammert et al., 2001; Matsumoto et al., 2001) 
. During kidney formation, intermediate mesoderm precursor cells expressing the Wilms'
Use of chemical genetics allows precise temporal and dosage control of receptor inhibition tumor suppressor gene (wt1) migrate toward the midline and coalesce around a vascular sprout from the aorta to form the Unlike antisense targeting strategies, this antiangiogenic compound can be administered at any stage of development to glomerulus ). These cells mark the bilateral pronephric primordia by 36 hpf ( Figure 3A ) that develop block the formation of particular blood vessels as they develop during the first few days of embryonic and larval life (data not into the midline glomerulus by 48 hpf ( Figure 3B ). In the zebra- has been shown to upregulate its activity (Fulton et al., 1999;  c Intersegmental vessels at Ͼ50% the normal number. d Intersegmental vessels at 30-50% the normal number.
Overexpression of the downstream effector AKT/PKB
Dimmeler et al., 1999). Using mRNA encoding either an actie Intersegmental vessels at Ͻ30% the normal number.
vated form of eNOS (S1179D, which mimics the AKT/PKB phosf Embryos were treated at 24 hpf, with 10 M of PTK787/ZK222584. Drug was phorylation) or an AKT/PKB-resistant version, S1179A, in drug washed out at 30 hpf and embryos were examined at 48 hpf.
washout experiments, we observed a modest rescue in the g Embryos were injected with either VEGFA3 morpholino alone or in combination with myrAKT mRNA at the one-cell stage and examined at 52 hpf.
number of intersegmental vessels with the activated version of Abbreviations: PTK787, PTK787/ZK222584; 18S, 18-somites; hpf, hours postfereNOS. The rescue was statistically significant but not as robust tilization.
as that seen with AKT/PKB ( Figure 5 and Table 1 ). Experiments in cultured endothelial cells suggest that the overexpressed AKT/PKB could be acting, at least in part, by preventing endothelial cell apoptosis (Gerber et al., 1998; Fujio and Walsh, 1999 ), but we wondered if our mRNA injections shown). From 24 hpf to 48 hpf, the development of the intersegwere having more global effects on cell survival. To investigate mental vessels in the zebrafish can be easily visualized using this, we determined the extent of apoptosis in whole-mount live embryo microangiography Isogai et TUNEL assays (Figure 6 ). In control embryos, we observed the al., 2001), where a fluorescent dye is injected into the embryonic naturally occurring apoptosis in the neural tube at 48 hpf (Figures circulation (Figure 4) . When embryos are treated with PTK787/ 6A and 6B). When embryos are treated with drug after the ZK222584 after the establishment of blood flow in the dorsal establishment of blood flow by 24 hpf, the amount of apoptotic artery and cardinal vein at 24 hpf, the intersegmental vessels cell death in the region of the dorsal artery and vein is dramatifail to form (Table 1) .
cally increased (Figures 6C and 6D ). In contrast, when embryos Since PTK787/ZK222584 is a reversible competitor, we peroverexpressing activated AKT/PKB are exposed to the same formed drug washout experiments where embryos were treated drug treatment, the amount of apoptotic cell death is reduced with the compound from 24 hpf to 30 hpf, after which the drug to background levels in the region of the blood vessels (Figures was removed by serial washes in embryo media before an incu-6E and 6F). However, exogenous AKT/PKB activity did not apbation period in drug-free embryo media ( Figure 4C and Table  pear to have a protective effect on the normal apoptosis in the 1). We observed that after drug removal, some intersegmental neural tube. The specificity of PTK787/ZK222584 effects on vessels are formed. However, these rescued vessels are markendothelial cells is underscored by comparison with wortmannin edly fewer in number as compared with same-stage control treatment of live embryos, where a high level of apoptotic cell death was observed throughout the embryo (Figures 6G and 6H ). embryos ( Figures 4B and 4C) . Antisense RNA staining of whole-mount embryos, dorsal views with anterior to the left in all panels. A-F: Kidney glomerular assembly was examined using the wt1 probe. Control embryos at 36 hr (A) and 48 hr (B) stained with wt1 show the migration of the bilateral podocytes (red arrows) toward the midline where fusion occurs by 48 hpf as indicated by the green arrow. When embryos are treated with PTK787/ZK222584 at shield stage (60% epiboly, 6 hpf) before aortic blood flow, the wt1-positive cells do not fuse at the midline (D, E, and F). PTK787/ZK222584-treatment after aortic flow at 26 hpf in C. Migration of wt1-positive podocytes toward the midline appears unaffected. G-L: insulin, trypsin, and fkd2 staining of control (G, I, and K) and PTK787/ZK222584-treated (H, J, and L) embryos, showing the locations of the endocrine pancreas, the exocrine pancreas, and the liver, respectively. Abbreviations: PTK787, PTK787/ZK222584 treatment. Scale bar for all panels indicates 200 m.
Inhibitors of serine/threonine kinases can phenocopy
likely secondary to the gross deformity in the trunk ( Figures 7E  and 7F ). known defects To see if the zebrafish could be used to study both tyrosine Discussion and serine/threonine kinase inhibitors, we also tested the effectiveness of a broad spectrum protein kinase C inhibitor, PKC412
The use of an inhibitor in place of the classic loss-of-function (Meyer et al., 1989) , and an inhibitor of MEK, U0126 (Favata et mutation allows us to perform experiments which would be al., 1998). Treatment of zebrafish embryos with PKC412 generextremely difficult or impossible in the fish using either mutations ated a distinctive curvature of the body axis which phenocopies in the VEGF receptors or downregulation via antisense or RNA that of the genetic zebrafish mutant, heart and soul (has) (Stainier interference technology. During the development of the verteet al., 1996; Figures 7A-7D) . Recent work has shown that the brate organism, the exact timing of developmental events is has mutant harbors stop codons in the coding region of an crucial to the formation of tissues and organ systems. A chemiatypical protein kinase C gene, PKC (Peterson et al., 2001;  cal genetic approach permits both temporal and dosage control Horne , 1993) . To examine the effects of these genic process. In addition, the drug also allows us to block compounds on zebrafish angiogenesis, we performed in situ multiple receptor alleles in one facile step. RNA staining with the endothelial marker flk-1 (Figures 7G-7J) .
To study signaling components in this pathway, we borAt 24 hpf, PKC412-treatment did not significantly reduce endorowed an idea from Drosophila studies where genetic rescue thelial cell staining as compared with control or has embryos of a hypomorphic allele is commonly used in pathway mapping ( Figures 7G-7I) . Thus, PKC412 did not generate antiangiogenic (Simon et al., 1991) . We reasoned that when the VEGF receptor effects as PTK787/ZK222584 when used on live zebrafish emwas impaired, a low level activity of a downstream component bryos in the same treatment regime (Figures 7G-7I; Figure 2) . might provide just enough pathway activation to achieve the Similar examination of U0126 effects showed that endothelial signaling threshold necessary for endothelial cell function. Previcells are present but their expression domain is deformed (Fig- ous work in cultured endothelial cells has shown that the AKT/ PKB branch of PI 3-kinase signaling is essential for VEGF-mediure 7J). The morphological changes in flk-1-positive cells are show the 95% confidence limits. Only myrAKT/PKB and eNOS S1179D show and posterior cardinal vein at 24 hpf, embryos were treated with PTK787/ statistically significant differences (p Ͻ 0.05) from GFP-injected fish, both at ZK222584 for a period of 6 hr, the drug was washed out at 30 hr, and the p Ͻ 0.0001 by two-tailed unpaired t test. embryos were allowed to recover until 48 hpf before microangiography. Note the reduced number of intersegmental vessels in C. Embryo in D was injected with myristoylated-AKT/PKB mRNA at the one-cell stage before drug treatment, and displayed more vessels. Abbreviations: PTK787, PTK787/ ZK222584 treatment; AKTϩPTK787, injected with AKT/PKB mRNA before higher levels, AKT/PKB overexpression generated gastrulation cally significant but very modest rescue ( Figure 6 and Table 1 ). Since AKT/PKB is upstream of eNOS in its signaling pathway (Fulton et al., 1999; Dimmeler et al., 1999) , it is perhaps not surprising that AKT/PKB generates a more robust rescue. ated cell survival and migration (Gerber et al., 1998; Our study serves to illustrate the interdependence of signal Morales-Ruiz et al., 2000) . We tested the ability transduction research and inhibitor drug action. There is a cerof AKT/PKB to provide a functional bypass in receptor blockage tain reciprocity in the information flow arising from studying the by looking at vessel recovery after a 6 hr exposure to PTK787/ interaction of potential drugs in zebrafish: the fish can give us ZK222584. Judging by the number of intersomitic vessels information about compounds under study, but the compounds formed after washout, we determined that a low level of exogecan also reveal the mechanisms regulating development. Highly nous AKT/PKB activity generated a much more robust rescue specific inhibitors can help us immensely in elucidating signal than in uninjected controls (see Table 1 ). Thus, endothelial cell transduction pathways, while the flaws of less specific comfunction, in this case, as indicated by the ability to migrate into pounds may be revealed by their effects on development. the intersomitic region and form functional vessels, is rescued PTK787/ZK222584 is specific and hence has provided us valuin the presence of increased AKT/PKB activity (Figure 4 and able information about the VEGF receptor signaling pathway in Table 1 ). Since AKT/PKB is a molecule with ubiquitous expresangiogenesis and allowed us to examine the consequences of sion and pleiotropic effects, we cannot rule out the possibility receptor inhibition on organ development in an intact organism. that AKT/PKB is acting in a pathway independent from the VEGF The absolute lack of blood flow that resulted from chemical receptor signaling pathway. However, our data is much more inhibition at early stages prevented glomerulogenesis during easily explained by the simple hypothesis that rescue occurs kidney formation as predicted from previous studies (Figures for VEGF signaling. Notably, upregulated AKT/PKB activity was 3A-3F; Serluca et al., 2002) . The formation of the endocrine able to rescue the VEGF receptor defect created by the drug, pancreas, as marked by insulin staining, does not appear differbut not the naturally occurring apoptosis in the neural tube.
ent after drug treatment, suggesting that the lack of an intact Since, by design, the 6 hr pulse of drug in washout experiments aortic endothelium and blood flow is insufficient to alter pancrehad been tailored to leave considerable residual VEGF receptor atic development at this stage. In studies in mouse and Xenopus, function, we would expect that the levels of AKT/PKB activity the development of the endocrine pancreas has been shown needed to rescue drug action would not be sufficient to rescue to depend on interactions with the endothelium (Lammert et al., natural apoptosis. Unfortunately, we were not able to further 2001). It is possible that in the fish, endothelial interactions are test this hypothesis by raising AKT/PKB activity still higher in an attempt to rescue cell death in the neural tube, because at not required for pancreatic development, or alternatively there flh mutants, like our drug treated fish, still display limited numbers of endothelial cells (Fouquet et al., 1997) , perhaps enough for induction of the endocrine pancreas. As recent data suggested a requirement for sonic hedgehog (shh) signaling in zebrafish pancreatic specification (Roy et al., 2001) , we also confirmed that shh expression is not altered in our chemical inhibitions (data not shown). Although the general staining and morphological location of the endocrine and exocrine pancreas, as well as the liver primordia, appear to be correct, the expression domains of two of these markers are reduced along the anterior-posterior axis ( Figures 3G-3L ), suggesting that endothelial signals may be required for organ morphogenesis without affecting cellular differentiation. In the case of liver development, our preliminary analysis is consistent with that of Matsumoto et al. (2001) in flk-1/VEGFR-2 null mice, which showed that specification of the liver does occur in the absence of vessels. These data suggest that our system can be further developed to explore developmental questions in organogenesis in an intact animal without surgical manipulation. Since signals between endothelial cells and developing tissues during organogenesis may be reprised during tumor angiogenesis, understanding these interactions may improve our understanding of cancer biology.
In these proof of concept experiments, the drug target was already known, but we feel that the system could be of value in determining the mechanisms of action of novel compounds. If PTK787/ZK222584 targets had been unknown, its potent antiangiogenic effects on the fish would have pointed to the correct pathway if not to the exact target. Our rescue experiment suggests that it may be possible to locate the target of a drug within a pathway by overexpressing various pathway members. In the course of this study, we have also tested serine/threonine kinase inhibitors, PKC412 and U0126, for their ability to induce specific phenotypes in the zebrafish. PKC412 generated a distinctive curvature of the body axis which phenocopied that of the genetic zebrafish mutant, heart and soul (has) (Stainier et al., 1996) , which resulted from mutations in the protein kinase C gene, PKC (Peterson et al., 2001; Horne-Badovinac et al., 2001 ). In that PDGF receptor inhibition would generate pigment defects (Smith et al., 1991; Stephenson et al., 1991) . To address these concerns in a more general way, we used a VEGF ligand morpholino to block the VEGF receptor may be a sufficient number of endothelial cells in drug treated pathway. We were able to obtain a specific antiangiogenic phefish to allow pancreas formation. In the zebrafish, the notochord, notype that could, with some difficulty, be rescued by coinjecwhich is required for dorsal artery formation (Fouquet et al., tion with myristoylated AKT/PKB mRNA (Table 1) . By lowering 1997), does not appear to be a source of inductive signals in the amount of VEGF-A morpholino injected, while adjusting the pancreatic development. The genetic mutant, floating head, flh, amount of myristoylated AKT/PKB mRNA in the coinjection exwhich lacks a notochord, still exhibits normal insulin expression in the proper morphological location (Biemar et al., 2001 ). The periment, we were able to generate more intersegmental vessels at 48 hpf, compared with embryos injected with the lowered cient and quick system for a prescreen. A single person can generate thousands of animals and test numerous compounds VEGF-A morpholino alone (Table 1) .
on a daily basis. The rapid development of the transparent Inevitably the system will fail to assess some compounds zebrafish embryo permits easy visual analysis of phenotypic correctly. For instance the zebrafish homolog of the c-Kit recepdefects. In addition, accumulating genetic data from zebrafish tor is well conserved, and yet STI571, a potent inhibitor of the mutants will provide a growing database for phenotypic comboth c-Abl and c-Kit kinases, fails to phenocopy a genetic c-kit parison of functional loss in a given signaling pathway. mutation (Parichy et al., 1999) or indeed have any effect on zebrafish development (J.C. and T.M.R., unpublished data).
Experimental procedures
However, our experience to date suggests that the zebrafish system will be useful in evaluating many signaling drugs. In
Maintenance of zebrafish and drug treatments particular, we suggest that the zebrafish system can play a Breeding fish were maintained at 28.5ЊC on a 14 hr light/10 hr dark cycle. Embryos were collected by natural spawning, raised in 10% Hank's saline, useful role as an initial animal screen before investment in more and staged up to 24 hr (30 somites) according to Kimmel et al. (1995);  costly and time-consuming rodent studies. No model system is perfect, but the zebrafish system offers Kinase inhibitors, PTK787/ZK222584, and PKC412 (Novartis Pharma AG, a unique combination of advantages that strengthen its potential Basel, Switzerland), were dissolved in DMSO at stock concentrations of 2 as a prescreen model for drug evaluation. It is inexpensive; at mM; U0126 (Promega) was dissolved at 50 mM in DMSO, then diluted in less than 1% of the cost of maintaining mice, the number of embryo media (Westerfield, 1995) and added to live zebrafish embryos at the stages indicated. Control embryos were treated with the equivalent embryos available for drug treatment can be much higher. As amount of DMSO solution. All embryos are incubated at 28.5ЊC. the sample numbers increase, statistical confidence in the outcome of the experiment improves. Equally importantly, the Isolation and characterization of cDNA clones amount of a compound required is small. In the course of this for VEGFR-2 and AKT␤/PKB-2 study we tested over 30,000 animals, with less than 5 mg of The cDNAs encoding rat EphA8 receptor tyrosine kinase domain (Chan and Watt, 1991) and the human AKT-1/PKB-␣ (Ramaswamy et al., 1999) were PTK787/ZK222584 for the entire study.
used to screen an 18 hr zebrafish embryonic cDNA library at low stringency The sequencing of the human genome has revealed an ex- (Chan et al., 2001) . Full-length cDNA clones were isolated encoding zebrafish tremely large number of potential targets for drug design. How-VEGFR-2/flk-1/KDR receptor and AKT-2/PKB␤: VEGFR-2, AKT-2/PKB␤ ever, candidate drugs require extensive testing in model ani-(GenBank accession numbers: AY056466, AY056465, respectively). Nucleomals. Current mammalian models are expensive to house and tide sequences were determined using the dideoxy method by the DanaFarber Cancer Institute Molecular Biology Core Facility.
time-consuming to use. The zebrafish can provide a cost-effi-
